Commonwealth Equity Services’s Aquestive Therapeutics AQST Stock Holding History

Commonwealth Equity Services’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.35M	Sell	1,046,175 -36,505	-3%	-$154K	0.01%	1517
2026 Q1	$4.49M	Buy	1,082,680 +62,888	+6%	+$255K	0.01%	1406
2025 Q4	$6.59M	Sell	1,019,792 -38,933	-4%	-$243K	0.01%	1138
2025 Q3	$5.92M	Buy	+1,058,725	New	+$4.58M	0.01%	1223

Other funds holding AQST

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

SMAM

Sugar Maple Asset Management Sister Bay, Wisconsin $155M AUM 17.72% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

SWRP

Summit Wealth & Retirement Planning San Ramon, California $472M AUM 25.49% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Commonwealth Equity Services's AQST Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Aquestive Therapeutics (AQST) stake by 3.4% in Q2 2026, selling an estimated $154K and leaving 1,046,175 shares worth $4.35M. The position accounts for 0.01% of the portfolio, ranked #1517.

Commonwealth Equity Services first reported a position in AQST in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.59M in Q4 2025. 32 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

Commonwealth Equity Services held 1,046,175 shares of Aquestive Therapeutics worth $4.35M as of Q2 2026.
Commonwealth Equity Services sold 36,505 Aquestive Therapeutics shares in Q2 2026, an estimated $154K.
Aquestive Therapeutics made up 0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #1517 holding.
Commonwealth Equity Services first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 4 quarters since.
Commonwealth Equity Services's Aquestive Therapeutics position peaked at $6.59M in Q4 2025.
32 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.